SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-118605
Filing Date
2016-08-12
Accepted
2016-08-12 12:50:06
Documents
50
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v445807_10q.htm 10-Q 361479
2 EXHIBIT 31.1 v445807_ex31-1.htm EX-31.1 9769
3 EXHIBIT 31.2 v445807_ex31-2.htm EX-31.2 9612
4 EXHIBIT 32.1 v445807_ex32-1.htm EX-32.1 5215
5 EXHIBIT 99.1 v445807_ex99-1.htm EX-99.1 73846
6 GRAPHIC tex99-1logo.jpg GRAPHIC 6768
  Complete submission text file 0001144204-16-118605.txt   2927906

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fencf-20160630.xml EX-101.INS 645074
8 XBRL TAXONOMY EXTENSION SCHEMA fencf-20160630.xsd EX-101.SCH 34714
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20160630_cal.xml EX-101.CAL 19859
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20160630_def.xml EX-101.DEF 177422
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20160630_lab.xml EX-101.LAB 223520
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20160630_pre.xml EX-101.PRE 201678
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 161827328
SIC: 2836 Biological Products, (No Diagnostic Substances)